Diagnos Laboratorium Utama Tbk. vs Logindo Samudramakmur Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Logindo Samudramakmur Tbk. trades at Rp108 (market cap 655.36B, 15.22M 24h volume). The key difference: Logindo Samudramakmur Tbk. is far larger — about 2.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Logindo Samudramakmur Tbk. is more actively traded (15.22M versus 41.7K). Which is the better fit depends on your goals.
| DGNS | LEAD | |
|---|---|---|
Market Cap | 316.25B | 655.36B |
Volume | 41.7K | 15.22M |
Lot | 417 | 152.25K |
Turnover | 9.66M | 1.67B |
Average Price | 231.65 | 109.39 |
Value | 9.66M | 1.67B |
Indicative Equilibrium Price | 230 | 108 |
Indicative Equilibrium Volume | 2.4K | 1.95K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Logindo Samudramakmur Tbk (the Company) is domiciled and was established in Jakarta, Indonesia based on Notarial Deed No. 55 of Nurul Hidajati Handoko, SH., Public Notary in Jakarta dated August 23, 1995. The company currently owns and operates a fleet of 58 offshore support with various types and functions. The company has a portfolio of customers ranging from mining oil and gas local to multinational.
Read more on LEAD →